Dr. Maiko Katadae focuses on the biotech and healthcare fields, taking charge of due diligence in life science technol-ogies and investment operations for seed and early-stage venture enter-prises. She invested in PeptiDream Inc. (listed in the TSE Mothers in June 2013 and the first section in December 2015) which utilizes special peptide manufacturing techniques to design new pharmaceutical drugs. She built management teams and was involved in business plans and development. She also served as an auditor.
Maiko graduated from the Department of Science at Ochanomizu University, completed the Master’s program in Chemistry and PhD in Science at the Department of Biological Sciences, Graduate School of Science in the University of Tokyo. She was selected as one of the 100 Influential People of Japan in 2013 by the Nikkei Business Magazine and won the Semi-Grand Prize for Woman of the Year 2014 by Nikkei.